Category - Executive Moves

Executive Moves

Maxim names Mario Leite as a senior healthcare banker

Maxim Group expanded its healthcare investment-banking group with the appointment of Mario Leite as a managing director.

February 6, 2019

Executive Moves

BioSig appoints John Kowalski as VP of sales

BioSig Technologies (NASDAQ:BSGM) named John Kowalski as VP of sales to lead the commercial launch of the PURE EP signal acquisition and processing system, which is designed to improve the diagnosis and treatment of...

February 5, 2019

Executive Moves

Ocutrx Vision names Dr. Linda Lam as chief scientific and strategy officer

Closely-held Ocutrx Vision Technologies appointed Dr. Linda Lam as chief scientific and strategy officer to guide new technology development, and help align current and future R&D efforts, industry trends and growth...

January 16, 2019

Executive Moves

Prometic names Prof. Simon Best as interim CEO

Prometic Life Sciences (TSX:PLI; OTCQX:PFSCF) named Prof. Simon Best as interim CEO, effective immediately, succeeding Pierre Laurin, who has stepped down from his management and board responsibilities.

December 20, 2018

Executive Moves

Novavax promotes Jill Hoyt and Biegie Lee

Novavax (NASDAQ:NVAX) promoted Jill Hoyt to SVP of human resources and Biegie Lee to VP of information technology.

December 5, 2018

Executive Moves

Kelley Dealhoy joins Interface Biologics as VP of business development

Closely-held Interface Biologics (IBI) appointed Kelley Dealhoy to the position of VP business development.

December 4, 2018

Executive Moves

Richard Gormley joins HCW as vice chairman, president of capital markets

Richard Gormley has joined investment bank, H.C. Wainwright, as vice chairman and president of capital markets. Mr. Gormley has over 30 years of experience in the investment banking and capital markets business, having...

November 19, 2018

Executive Moves

Jerry Isaacson joins Roth as managing director and senior research analyst

Jerry Isaacson has joined Roth Capital Partners as a managing director and senior research analyst covering biotechnology and emerging therapeutics.

November 5, 2018

Executive Moves

Breath Therapeutics names Peter Shadday as chief commercial officer

Closely-held Breath Therapeutics appointed Peter Shadday as chief commercial officer to lead the company’s market access activities and product commercialization.

October 17, 2018

Executive Moves

ContraVir Pharma names biotech industry veteran, Robert Foster, as acting CEO

ContraVir Pharmaceuticals (NASDAQ:CTRV) appointed industry veteran, Robert Foster, as acting CEO, succeeding James Sapirstein.

October 3, 2018

Category - Executive Moves

Maxim names Mario Leite as a senior healthcare banker

BioSig appoints John Kowalski as VP of sales

Ocutrx Vision names Dr. Linda Lam as chief scientific and strategy officer

Prometic names Prof. Simon Best as interim CEO

Novavax promotes Jill Hoyt and Biegie Lee

Kelley Dealhoy joins Interface Biologics as VP of business development

Richard Gormley joins HCW as vice chairman, president of capital markets

Jerry Isaacson joins Roth as managing director and senior research analyst

Breath Therapeutics names Peter Shadday as chief commercial officer

ContraVir Pharma names biotech industry veteran, Robert Foster, as acting CEO

General

More